A microprocessor-control led automatic extractor, (PREMTM )0 is described with which lipophilic components may be extracted from physiological fluids by means of a selective, solid-phase extraction cartridge, and the extracts presented in dry form for subsequent analysis. This instrument has been successfully evaluated for the extraction of phenobarbital, primidone, and phenytoin from human serum before chromatographic analysis. We describe a specific method for determination of these anticonvulsants, inVolving the PREP I and analysis, after flash-heater methylation, in a gas chromatograph equipped with a nitrogen-sensitive detector. Absolute recoveries ranged from 90 to 102%. Within-day and day-to-day precision (CV) ranged from 4 to 7% for all three drugs in therapeutic concentrations.
A microprocessor-control led automatic extractor, (PREMTM )0 is described with which lipophilic components may be extracted from physiological fluids by means of a selective, solid-phase extraction cartridge, and the extracts presented in dry form for subsequent analysis. This instrument has been successfully evaluated for the extraction of phenobarbital, primidone, and phenytoin from human serum before chromatographic analysis. We describe a specific method for determination of these anticonvulsants, inVolving the PREP I and analysis, after flash-heater methylation, in a gas chromatograph equipped with a nitrogen-sensitive detector. Absolute recoveries ranged from 90 to 102%. Within-day and day-to-day precision (CV) ranged from 4 to 7% for all three drugs in therapeutic concentrations.
Comparison of this method with results obtained with a liquid-liquid micro-scale extraction and a similar gas-chromatographic method resulted in correlation coefficients of 0.988 (phenobarbital), 0.978 (primidone), and 0.982 (phenytoin). relative to the outer rotor. The rotor is divided into 12 pieshaped compartments (Figure 1 ), each of which has designated positions for the components of the extraction cartridge.
The extraction column is placed in the inner rotor position A, the effluent cup in outer rotor position B, and the recovery cup in outer rotor position C. The outer rotor positions are keyed so that the effluent and recovery cups may not be interchanged. Owing to the relative movement of the inner and outer rotors, the tip of the extraction column is aligned with the effluent cup when the rotor is accelerated in a clockwise direction.
Conversely, the tip of the extraction column is aligned with the recovery cup when the rotor is turning in a counter-clockwmse direction (Figure 2 ). This provides for two separate flow paths, and permits the separation and collection of two fractions.
The Type W extraction cartridge (Du Pont) was used for all extractions.
It is made up of four components, which are nested together: a cap, an extrction column, an effluent cup, and a recovery cup (Figure 3 ). The resin in the Type W cartridge, a polystyrene-divinylbenzene copolymer, is lipophilic in nature and has been specially treated to accept a biologmcal sample. The cap and the effluent cup seal the extraction column and preserve the integrity of the resin bed. The recovery cup is the vehicle that carries the dry extract and the sample identification.
A Model 3920B gas chromatograph (Perkin-Elmer Corp., Norwalk, CT 60856) equipped with a nitrogen/phosphorus detector was used for the analytical work. The gas chromatograph was fitted with a flash heater injector maintained at 300 #{176}C. A 2 mm X 1.8 m glass column was packed with 3% OV-17 on Chromosorb W-HP 100/120 (Perkin-Elmer). Helium was used as the carrier gas at a flow rate of 35 mL/min. Oven temperature was programmed from 170 to 280 #{176}C, at 16 #{176}C/min, and held at 280 #{176}C for 2 mm. The detector was operated in the nitrogen mode at 300 #{176}C. The flow rate of air was 100 mL/min and of hydrogen 5 mL/min. A Perkin-Elmer Model 023 recorder was used, 0-1 mV full scale at 0.5 cm! mm. in the effluent cup as the rotor spins in a clockwise direction.
Chemicals
A high-speed spin is used to remove excess water from the resin bed before the rotor slows and reverses direction. The co-elute with the drugs, they may complicate identification of the peaks produced by the drugs and prolong total analysis time.
Results and Discussion
Absolute analytical recoveries for phenobarbital, primidone, and phenytoin were determined by comparing the PREP I extracts of drug-supplemented serum to a calibration curve prepared from unextracted standards. In both cases, an external standard was used to compensate for volumetric and injection errors. The absolute recoveries (n = 10) were: phenobarbital 102 ± 2%, primidone 98 ± 3%, and phenytoin 102 ± 2%. Precision, both within-day and day-to-day, for therapeutic concentrations is good (Table 1) , the CV being <4.1%. For subtherapeutic concentrations the CV is <7.2% for all three drugs. The sample volume may be decreased to 50 LL and, together with a reduction in the volumes of solvents 1 and 2, the extraction time may be shortened to 16 mm (Program 2). For this micro-scale PREP I procedure, within-day precision (CV) was: phenobarbital (15 mg/L) 3%, primidone (7 mg/L) 8%, and phenytoin (7 mg/L) 4%.
The linear regression data and the correlation coefficients for the PREP I extracts and the micro liquid-liquid extraction are shown in Table 2 . Some drugs were screened for possible interference with this PREP I-gas chromatographic method (Table 3) . To be classified as an interference, a compound must be extracted under the same PREP I conditions, have a retention time similar to the drugs or internal standards, and be detectable under the same chromatographic conditions. Therapeutic concentrations of theophylline (10-20 mg/L) or caffeine (10-14 mg/L) will significantly interfere with the quantitation of phenobarbital. However, the caffeine concentration in the serum after a usual coffee intake will not interfere. Except for theophyllmne, caffeine, glutethimide, and mephobarbital, none of the drugs listed in Table 3 interferes. By selecting appropriate extraction and chromatographic conditions, methods could be developed for monitoring many of these drugs in therapeutic concentrations. There were no interferences from hemolytic or lipemic samples. However, there were two interferences attributed to blood-collection tubes. Tnibutoxyethyl phosphate, a plasticizer, is present in the rubber stopper of certain blood-collection tubes. It was identified as the peak that was incompletely resolved from the 5-(p-methylphenyl)-5-phenylhydantoin internal standard in some of the extracts. It did not affect the quantitation of any of the drugs, but it complicates peak identification.
We saw a peak (unidentified) with the same retention time as primidonein some of the extracts, and definitely have associated it with use of the blood-collection tubes. These two peaks were demonstrated in drug-free samples collected in Vacutainer Tubes (Becton-Dickinson, Rutherford, NJ 07070) as well as "J-VAC" pediatric tubes NDC 8003-006003 (Jelco, Raritan, NJ). These peaks were not demonstrated in "Corvac" tubes (no. 430139; Corning Glass Works, Corning, NY) or in J-VAC tubes no. 8003-006500 and no. 8003-006005. In any situation where a nitrogen/phosphorus detector is used, blood-collection tubes that have stoppers containing plasticizers should be avoided.
